Gonococcal infection of lower genitourinary tract, unspecified
ICD-10 A54.6 is a billable code used to indicate a diagnosis of gonococcal infection of lower genitourinary tract, unspecified.
Gonococcal infection of the lower genitourinary tract is caused by the bacterium Neisseria gonorrhoeae, a sexually transmitted infection (STI) that primarily affects the urethra in men and the cervix in women. This infection can lead to a range of complications if left untreated, including pelvic inflammatory disease (PID) in women and epididymitis in men. Symptoms may include dysuria, increased urinary frequency, and purulent discharge. However, many individuals may be asymptomatic, particularly women, which complicates diagnosis and increases the risk of transmission. Gonococcal infections can also co-occur with other STIs, necessitating comprehensive screening and treatment. The unspecified designation indicates that the clinical documentation does not specify the exact site of infection within the lower genitourinary tract, which can affect treatment decisions and public health reporting. Effective management includes appropriate antibiotic therapy, patient education on safe sexual practices, and contact tracing to prevent further spread of the infection.
Detailed patient history, symptomatology, and treatment plans.
Management of STIs, including gonococcal infections and co-infections.
Consideration of local epidemiology and resistance patterns in treatment.
Urological examination findings, patient history, and treatment response.
Diagnosis and management of urethritis and related complications.
Documentation of any surgical interventions or complications.
Used for confirming diagnosis of gonococcal infection.
Document the reason for testing and results.
Infectious disease specialists may require additional lab results.
Common symptoms include dysuria, purulent discharge, and pelvic pain. However, many individuals may be asymptomatic.
Treatment typically involves dual antibiotic therapy, often including ceftriaxone and azithromycin.
Contact tracing helps to identify and treat sexual partners, reducing the spread of the infection.
